Discovery and development of Janus Kinase (JAK) inhibitors for inflammatory diseases: Miniperspective
JD Clark, ME Flanagan, JB Telliez - Journal of medicinal chemistry, 2014 - ACS Publications
The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential
role in the signaling of numerous cytokines that have been implicated in the pathogenesis of …
role in the signaling of numerous cytokines that have been implicated in the pathogenesis of …
Jaks and STATs: biological implications
WJ Leonard, JJ O'Shea - Annual review of immunology, 1998 - annualreviews.org
▪ Abstract Cytokines and interferons are molecules that play central roles in the regulation of
a wide array of cellular functions in the lympho-hematopoietic system. These factors …
a wide array of cellular functions in the lympho-hematopoietic system. These factors …
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Lymphomas arising from NK or γδ-T cells are very aggressive diseases and little is known
regarding their pathogenesis. Here we report frequent activating mutations of STAT3 and …
regarding their pathogenesis. Here we report frequent activating mutations of STAT3 and …
Cytokine control of memory T-cell development and survival
KS Schluns, L Lefrançois - Nature Reviews Immunology, 2003 - nature.com
Evidence has accumulated that cytokines have a fundamental role in the differentiation of
memory T cells. Here, we follow the CD8+ T cell from initial activation to memory-cell …
memory T cells. Here, we follow the CD8+ T cell from initial activation to memory-cell …
Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection
ME Flanagan, TA Blumenkopf… - Journal of medicinal …, 2010 - ACS Publications
There is a critical need for safer and more convenient treatments for organ transplant
rejection and autoimmune disorders such as rheumatoid arthritis. Janus tyrosine kinases …
rejection and autoimmune disorders such as rheumatoid arthritis. Janus tyrosine kinases …
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for …
ML Vazquez, N Kaila, JW Strohbach… - Journal of medicinal …, 2018 - ACS Publications
Janus kinases (JAKs) are intracellular tyrosine kinases that mediate the signaling of
numerous cytokines and growth factors involved in the regulation of immunity, inflammation …
numerous cytokines and growth factors involved in the regulation of immunity, inflammation …
When aging reaches CD4+ T-cells: phenotypic and functional changes
MA Moro-García, R Alonso-Arias… - Frontiers in …, 2013 - frontiersin.org
Beyond midlife, the immune system shows aging features and its defensive capability
becomes impaired, by a process known as immunosenescence that involves many changes …
becomes impaired, by a process known as immunosenescence that involves many changes …
Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-γ induction is …
JA Gollob, JW Mier, K Veenstra, DF McDermott… - Clinical Cancer …, 2000 - AACR
The aim of this study was to examine the tolerability, antitumor activity, and biological effects
of a new schedule of iv recombinant human interleukin 12 (rhIL-12). Twenty-eight patients …
of a new schedule of iv recombinant human interleukin 12 (rhIL-12). Twenty-eight patients …
Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors
C Haan, C Rolvering, F Raulf, M Kapp, P Drückes… - Chemistry & biology, 2011 - cell.com
Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common
gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 …
gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 …
Leukemia-inhibitory factor—neuroimmune modulator of endocrine function
CJ Auernhammer, S Melmed - Endocrine reviews, 2000 - academic.oup.com
Leukemia-inhibitory factor (LIF) is a pleiotropic cytokine expressed by multiple tissue types.
The LIF receptor shares a common gp130 receptor subunit with the IL-6 cytokine …
The LIF receptor shares a common gp130 receptor subunit with the IL-6 cytokine …